Thomas Callihan serves as the Vice President of Finance and Group CFO at Agilent Technologies, where he leverages over 25 years of extensive experience in the Healthcare Diagnostics, Medical Devices, Life Sciences, and Consumer sectors. In his current role, Thomas provides strategic financial oversight for...
Thomas Callihan serves as the Vice President of Finance and Group CFO at Agilent Technologies, where he leverages over 25 years of extensive experience in the Healthcare Diagnostics, Medical Devices, Life Sciences, and Consumer sectors. In his current role, Thomas provides strategic financial oversight for Agilent's expansive $6 billion business portfolio, which encompasses commercial operations, marketing, analytics, and digital strategy. His leadership is instrumental in supporting the Chief Commercial Officer, ensuring that financial performance aligns with the company’s ambitious growth objectives.
Thomas’s expertise spans various domains, including financial reporting, modeling, and mergers & acquisitions, making him a pivotal figure in driving Agilent's financial strategy. He is adept at managing global P&L, balance sheets, and operating results, particularly within the Life Sciences industry, where he oversees a large multinational service franchise. His comprehensive understanding of supply chain dynamics and process improvement initiatives enables him to optimize financial performance while enhancing operational efficiency.
Throughout his career, Thomas has successfully navigated the complexities of both private equity environments, such as his tenure with the Carlyle Group, and public multinational corporations like Johnson & Johnson and Eastman Kodak. His diverse background as a Controller and in Financial Planning & Analysis (FP&A) equips him with a unique perspective on business development and strategic financial management. As he continues to lead Agilent's financial initiatives, Thomas remains committed to fostering innovation and driving sustainable growth in an ever-evolving industry landscape.